BIONIK Laboratories has entered into a purchase order with Clinique Les Trois Soleils in Boissise-le-Roi, France for its InMotion Arm robot.
The purchase order is for one of BIONIK’s improved InMotion Arm robotic systems, whose launch was announced this year and recently received a “CE marking” from the European Commission. The CE marking signifies that products sold in the European Economic Area (EEA) have been assessed to meet high safety, health and environmental protection requirements. Clinique Les Trois Soleils already owns three units of earlier models of the InMotion Arm and Wrist robotic systems.
Clinique Les Trois Soleils CEO Paul Gobin said: “We are thrilled to partner with BIONIK once again to provide innovative technology and therapeutic solutions to our patients. BIONIK’s InMotion Arm system has empowered our patients to succeed in their rehabilitation treatment, providing improved outcomes for many.
“We are always seeking out new technologies that can enhance the treatment we offer to our patients, and BIONIK’s InMotion Arm is an example of that commitment. We look forward to our continued relationship with BIONIK and to improving the lives of our patients on a daily basis through the use of industry-leading technology.”
Clinique Les Trois Soleils offers versatile and comprehensive rehabilitation programs for patients recovering from orthopedic, musculoskeletal or neurological injuries. It is the first private for-profit rehabilitation center in the Île-de-France region to develop a neurological arm rehabilitation robotics center, with 68 inpatient beds for patients undergoing rehabilitation following stroke, spinal cord injury, multiple sclerosis or other neurological conditions.
Clinique Les Trois Soleils has also published many key studies with the InMotion robotic systems and continues to conduct clinical trials with patients following stroke. Studies led by Dr. Christophe Duret and his colleagues have investigated the effectiveness of robotic therapy when combined with, or compared to, usual care, and demonstrated the beneficial impact of robotics on the motor recovery process.
BIONIK Laboratories CEO and director Eric Dusseux said: “We are excited to continue our terrific collaboration with Clinique Les Trois Soleils for another InMotion Arm robotic system.
“While developing new business pipelines is a priority, we are pleased to serve current customers through the purchase of additional units. We believe that the continued selection of BIONIK’s InMotion Arm by Clinique Les Trois Soleils validates to the European market that our technology is best positioned to provide optimal patient outcomes and become an integral part of a neurological therapy regimen.”
This transaction highlights the continued demand for BIONIK’s innovative InMotion Arm robotic system, as the Company sells or rents units to medical facilities in the United States and internationally, including recently to facilities in Florida and Texas.
The InMotion Arm is used in more than 20 countries to help stroke survivors and those with other neurological conditions to regain arm movement by training shoulder protraction/retraction, flexion/extension, abduction/adduction, internal/external rotation and elbow flexion/extension.
The improved InMotion Arm therapy was developed according to the principles of motor learning and neuro-plasticity. The therapy provides the same clinical efficacy as the original system developed over 28 years ago and extensively researched worldwide. InMotion Arm therapy guides the patient through specific tasks, aiming to improve motor control of the arm by increasing strength, range of motion and coordination, and assisting with the provision of efficient, effective, intensive sensorimotor therapy.
Source: Company Press Release